Next Science Limited
NXSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $16 | $20 | $50 | $55 |
| - Cash | $1 | $2 | $4 | $9 |
| + Debt | $5 | $2 | $1 | $1 |
| Enterprise Value | $21 | $21 | $47 | $46 |
| Revenue | $10 | $12 | $11 | $13 |
| % Growth | -9.4% | 3.1% | -10.8% | – |
| Gross Profit | $9 | $9 | $9 | $9 |
| % Margin | 83.2% | 81.9% | 79.8% | 73.1% |
| EBITDA | -$4 | -$4 | -$5 | -$7 |
| % Margin | -39% | -35.6% | -46.8% | -55.5% |
| Net Income | -$5 | -$5 | -$6 | -$8 |
| % Margin | -44.7% | -41% | -52% | -63.5% |
| EPS Diluted | -0.016 | -0.016 | -0.03 | -0.031 |
| % Growth | 1.2% | 46% | 2.3% | – |
| Operating Cash Flow | -$3 | -$3 | -$5 | -$8 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$3 | -$5 | -$8 |